Sort   by:  
 Page size 
UnknownPhase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer.
Not available
S-EPMC3200222 | biostudies-literature
UnknownPhase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer.
Not available
S-EPMC3083869 | biostudies-literature
UnknownOn the clinical interpretation of overground gait stability indices in children with cerebral palsy.
Not available
S-EPMC11530431 | biostudies-literature
UnknownEvaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.
Not available
S-EPMC2203231 | biostudies-literature
UnknownGenetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer.
Not available
S-EPMC3289753 | biostudies-literature
UnknownEffects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.
Not available
S-EPMC3210907 | biostudies-literature
UnknownInherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer.
Not available
S-EPMC4134100 | biostudies-literature
UnknownExpression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Not available
S-EPMC4681883 | biostudies-literature
UnknownIdentification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma.
Not available
S-EPMC4295492 | biostudies-literature
UnknownPARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy.
Not available
S-EPMC6397203 | biostudies-literature
Sort   by:  
 Page size